Effect of the MEK kinase inhibitor PD98059 on cytokine-mediated priming of arachidonate release in neutrophils
Stimulus, 1 μM . | PD98059, μM . | Priming agent, % control . | ||
---|---|---|---|---|
FCS . | TNF-α . | GM-CSF . | ||
FMLP | 0 | — | 100+ | 100 |
1 | — | 80 ± 3* | 88 ± 10 | |
5 | — | 61 ± 3* | 49 ± 25 | |
10 | — | 52 ± 8† | 50 ± 3* | |
15 | — | 53 ± 24 | 46 ± 8* | |
20 | — | 28 ± 6* | 40 ± 8† | |
30 | — | 30 ± 4* | 57 ± 4* | |
A23187 | 0 | 100 | 100 | 100 |
1 | 79 ± 19 | 82 ± 8 | 79 ± 11 | |
5 | 71 ± 22 | 66 ± 17 | 67 ± 14 | |
10 | 80 ± 25 | 48 ± 5† | 59 ± 8† | |
15 | 73 ± 24 | 42 ± 8† | 46 ± 15† | |
20 | 86 ± 18 | 44 ± 8† | 54 ± 8† | |
30 | 80 ± 21 | 38 ± 4* | 40 ± 7* |
Stimulus, 1 μM . | PD98059, μM . | Priming agent, % control . | ||
---|---|---|---|---|
FCS . | TNF-α . | GM-CSF . | ||
FMLP | 0 | — | 100+ | 100 |
1 | — | 80 ± 3* | 88 ± 10 | |
5 | — | 61 ± 3* | 49 ± 25 | |
10 | — | 52 ± 8† | 50 ± 3* | |
15 | — | 53 ± 24 | 46 ± 8* | |
20 | — | 28 ± 6* | 40 ± 8† | |
30 | — | 30 ± 4* | 57 ± 4* | |
A23187 | 0 | 100 | 100 | 100 |
1 | 79 ± 19 | 82 ± 8 | 79 ± 11 | |
5 | 71 ± 22 | 66 ± 17 | 67 ± 14 | |
10 | 80 ± 25 | 48 ± 5† | 59 ± 8† | |
15 | 73 ± 24 | 42 ± 8† | 46 ± 15† | |
20 | 86 ± 18 | 44 ± 8† | 54 ± 8† | |
30 | 80 ± 21 | 38 ± 4* | 40 ± 7* |
Purified neutrophils were incubated with PD98059 for 10 minutes at 37°C before priming and stimulation with agonist and measurement of arachidonate release as described in the legend to Table 1. Basal release of arachidonate in unstimulated samples was subtracted from the stimulated value, and the data were expressed as a percentage of DMSO diluent control. Absolute values were expressed as cpm/106cells for (1) FMLP stimulation: FCS, 123 ± 142; TNF, 2563 ± 950; and GM-CSF, 1130 ± 30; and (2) A23187 stimulation; FCS, 2472 ± 779; TNF, 5266 ± 1251; and GM-CSF, 10 050 ± 524. Release of arachidonate from unprimed FMLP-stimulated cells was not significantly different from background, therefore the percent of control values was not determined. The data shown are the mean ± SE of 4 experiments.
See Table 1 for abbreviations.
.01 > P > .001 indicates significant difference between samples with inhibitor.
.05 > P > .01 indicates significant difference between samples without inhibitor.